Lance Baldo Adaptive Biotechnologies Corp (ADPT) insider trading activity

ADPT Quotes by TradingView

Lance Baldo is Chief Medical Officer of Adaptive Biotechnologies Corp. Currently has a direct ownership of 17,171 shares of ADPT, which is worth approximately $132,388. The most recent transaction as insider was on Mar 08, 2022, when has been sold 3,350 shares (Common Stock) at a price of $11.43 per share, resulting in proceeds of $38,291. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.2K
0% 3M change
0% 12M change
Total Value Held $132,388

LANCE BALDO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 08 2022
SELL
Open market or private sale
$38,291 $11.43 p/Share
3,350 Reduced 16.32%
17,171 Common Stock
Mar 07 2022
SELL
Open market or private sale
$28,500 $12.01 p/Share
2,373 Reduced 10.37%
20,521 Common Stock
Apr 14 2021
SELL
Open market or private sale
$89,000 $44.5 p/Share
2,000 Reduced 8.03%
22,894 Common Stock
Apr 14 2021
BUY
Exercise of conversion of derivative security
$15,600 $7.8 p/Share
2,000 Added 7.44%
24,894 Common Stock
Mar 04 2021
BUY
Grant, award, or other acquisition
-
22,894 Added 50.0%
22,894 Common Stock
Jan 27 2021
SELL
Open market or private sale
$2,366,400 $59.16 p/Share
40,000 Reduced 100.0%
0 Common Stock
Jan 27 2021
BUY
Exercise of conversion of derivative security
$312,000 $7.8 p/Share
40,000 Added 50.0%
40,000 Common Stock
Dec 07 2020
SELL
Open market or private sale
$312,875 $50.06 p/Share
6,250 Reduced 100.0%
0 Common Stock
Dec 07 2020
BUY
Exercise of conversion of derivative security
$48,750 $7.8 p/Share
6,250 Added 50.0%
6,250 Common Stock
Nov 06 2020
SELL
Open market or private sale
$318,125 $50.9 p/Share
6,250 Reduced 100.0%
0 Common Stock
Nov 06 2020
BUY
Exercise of conversion of derivative security
$48,750 $7.8 p/Share
6,250 Added 50.0%
6,250 Common Stock
Oct 06 2020
SELL
Open market or private sale
$308,562 $49.37 p/Share
6,250 Reduced 100.0%
0 Common Stock
Oct 06 2020
BUY
Exercise of conversion of derivative security
$48,750 $7.8 p/Share
6,250 Added 50.0%
6,250 Common Stock
Sep 29 2020
SELL
Open market or private sale
$1,250,000 $50.0 p/Share
25,000 Reduced 100.0%
0 Common Stock
Sep 29 2020
BUY
Exercise of conversion of derivative security
$195,000 $7.8 p/Share
25,000 Added 50.0%
25,000 Common Stock
LB

Lance Baldo

Chief Medical Officer
Seattle, WA

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADPT